Hypertension Clinical Trial
Official title:
Effects of Changes in Calcium Dietary Intake on Blood Pressure and Body Weight Control
Mediterranean diet is relatively poor in calcium (about 700 mg/daily) whilst there are
several reports indicating beneficial effects of calcium-rich diets. Aim of the preset study
is to evaluate the effects of a low-sodium, low-lipid diet enriched in calcium, mainly from
vegetables instead of dairy products, on blood pressure, body weight a main parameters of
the glucose and lipid metabolisms.
This study is a randomized, parallel group trial that will be performed in the Outpatient
Clinic. At least 150 patients with arterial hypertension and/or increased body weight (IMC>
28 kg/m2) will enter the study program. After a 3 month low-lipid low-salt diet that will be
prescribed to all patients, they will be divided in two groups. The first will change the
diet to that similar for total calories, percent composition of macronutrients and salt but
enriched in calcium (about 1200 mg/daily) whilst the alternative group will continue the
first diet. The observation period will be of 1 year with anthropometric (body weight and
height, waist circumference), hemodynamic (blood pressure and heart rate) and metabolic
(cholesterol, triglycerides, fasting blood glucose, uric acid, calcium, phosphorus, sodium
and potassium) controls after 3-6 and 12 months.
The DASH Study showed that the antihypertensive effects of a low-salt, low-lipid diet were
significantly potentiated when the diet was enriched in calcium. This target may be reached
either increasing the daily consumption of low-lipid milk and dairy products or increasing
the daily consumption of calcium-rich vegetables.
In the Italian population the mean daily consumption of calcium is rather low, not exceeding
700 mg/daily whilst it would be desirable a daily consumption of 1200 mg/daily.
Unfortunately there are in Italy very few dairy products (particularly low-lipid cheese)
that would ensure a variable and palatable calcium-rich diet.
Aims of the present study are:
1. to prepare a low-sodium (about 3 g/daily) diet enrich in calcium (about 1200 mg/daily)
and to compare the effects on blood pressure with those of a low-sodium diet similar to
it in macronutrients but with a calcium content typical of the Mediterranean diet (no
more than 700 mg/daily) (see Table 1);
2. to verify if this diet is able to improve the control of body weight and of the main
parameters of the glucose and lipid metabolisms;
3. to evaluate if this diet is palatable enough to be prescribed in a long term study.
Patients:
At least 150 patients with arterial hypertension and/or overweight /obesity (IMC > 28 kg/m2)
will be enrolled.
Methods:
1. evaluation of nutritional habits by an adequate frequency questionnaire at baseline,
after a 3-month low-lipid low-sodium diet;
2. anthropometric measures (body weight, height, waist circumference);
3. measurements of blood pressure and heart rate;
4. measurements of serum total and HDL cholesterol serum triglycerides, fasting blood
glucose, serum sodium potassium calcium and phosphorus.
Design of the study:
This is a randomized parallel-group study performed in the Outpatient Clinic. Patients
enrolled in the study will be prescribed a low-sodium low-lipid diet for 3 months. At the
end of the first phase they will be randomly divided in two groups:
1. Group A: patients will change their diet in a diet similar for total daily calories,
sodium and macronutrients but enriched in calcium (1200 mg/daily) and will be followed
up to 1 year with an intermediate control after the first 3 months;
2. Group B: patients will continue the low-lipid, low-sodium diet up to 1 year with an
intermediate control after the first 3 months.
At baseline, after 3, 6 and 12 months of observation, patients will repeat the measurements
1-4 described in the Methods.
Composition in macro and micronutrients of the two diets
NUTRIENTS LOW-SODIUM DIET LOW-SODIUN CALCIUM- ENRICHED DIET PROTEINS (%) 17 17 LIPIDS (%) 27
28 SATURATED FATTY ACIDS (%) 7 7 MONOUNSATURATED (%) 16 17 POLTYUNSATURATED (%) 4 4
CHOLESTEROL ( mg) 132 140 CARBOHYDRATES (%) 56 54 SOLUBLE CHO (%) 18 17 FIBRE (g) 39 42 Na
(mg) 1397 1377 K (mg) 3973 4067 Fe (mg) 16 21 Ca (mg) 650 1211 P (mg) 1285 1501
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |